Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,664 JPY | +1.87% | +1.93% | +1.15% |
Apr. 25 | AstraZeneca upbeat as cancer drugs underpin sales growth | AN |
Apr. 08 | AstraZeneca hails neurological data for Ultomiris, Soliris | AN |
Business Summary
Number of employees: 864
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pachinko Machine-related
77.9
%
| 71,860 | 84.7 % | 122,576 | 77.9 % | +70.58% |
Pachislot Machine Related
14.3
%
| 8,891 | 10.5 % | 22,551 | 14.3 % | +153.64% |
Supply Equipment Related
7.6
%
| 3,895 | 4.6 % | 11,993 | 7.6 % | +207.91% |
Others
0.1
%
| 210 | 0.2 % | 175 | 0.1 % | -16.67% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 84,857 | 100.0 % | 157,296 | 100.0 % | +85.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Akihiko Ishihara
CEO | Chief Executive Officer | 61 | 86-03-31 |
Chairman | 71 | 77-03-31 | |
Sou Busujima
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Administrative Officer | - | - | |
Ichiro Tomiyama
COO | Chief Operating Officer | 66 | 86-10-31 |
Yoko Oshima
IRC | Investor Relations Contact | - | - |
Katsumasa Takai
PRN | Corporate Officer/Principal | - | - |
Toshio Ogura
PRN | Corporate Officer/Principal | - | - |
Yuji Togo
SAM | Sales & Marketing | - | - |
Takashi Fukuda
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 77-03-31 | |
Akihiko Ishihara
CEO | Chief Executive Officer | 61 | 86-03-31 |
Ichiro Tomiyama
COO | Chief Operating Officer | 66 | 86-10-31 |
Taro Kitani
BRD | Director/Board Member | 47 | 15-05-31 |
Director/Board Member | 69 | 18-06-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 310,583,500 | 145,874,115 ( 46.97 %) | 78,619,385 ( 25.31 %) | 46.97 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SANKYO CO., LTD. 15.64% | 40,651,855 | 15.64% | 449,642,851 $ |
1,401,000 | 9.56% | 24,808,754 $ | |
533,400 | 0.07% | 11,658,710 $ | |
200,000 | 0.70% | 8,431,068 $ | |
377,400 | 1.66% | 8,116,798 $ | |
RESONA HOLDINGS, INC. 0.03% | 666,750 | 0.03% | 4,186,543 $ |
DAIKOKU DENKI CO., LTD. 0.13% | 19,100 | 0.13% | 482,722 $ |
Company contact information
Sankyo Co., Ltd.
3-29-14 Shibuya Shibuya-Ku
150-8327, Tokyo
+81 3 5778 7777
http://www.sankyo-fever.co.jpSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.15% | 2.32B | |
+11.20% | 8.25B | |
+13.39% | 718M | |
+29.76% | 358M | |
+5.69% | 349M | |
+3.88% | 327M | |
-6.11% | 270M | |
+15.54% | 182M | |
+26.63% | 99.29M | |
-28.33% | 63.25M |
- Stock Market
- Equities
- 6417 Stock
- Company Sankyo Co., Ltd.